The Definitive Peptide Research Reference Guide — Compound Review

Severity: Mild

TB-500 Side Effects

TB-500 is generally well-tolerated in animal research. Human reports suggest mild side effects, with injection site reactions being the most commonly noted.

Medical Disclaimer: This page is for informational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before using any research chemical or peptide. TB-500 is not FDA-approved for human use (unless noted).

Common Side Effects

Injection Site Reactions

Redness, swelling, or mild pain at the injection site are the most frequently reported reactions.

Fatigue

Mild fatigue or lethargy reported by some users in the hours following administration.

Nausea

Mild nausea reported occasionally, typically with higher doses.

Head Rush / Lightheadedness

Brief lightheadedness immediately following injection, likely due to vasodilatory effects.

Rare or Serious Side Effects

Flu-like Symptoms

Some users report mild flu-like symptoms (malaise, low-grade fever) during the first week of use.

Headache

Mild headaches reported in a subset of users.

Contraindications

TB-500 should not be used in the following situations:

  • Active cancer or history of cancer (theoretical concern due to angiogenic properties)
  • Pregnancy or breastfeeding
  • Known hypersensitivity to any component

Frequently Asked Questions

Is TB-500 safe for humans?

TB-500 has not been studied in human clinical trials. Animal data suggests a favorable safety profile. Most reported human side effects are mild and transient.

Can TB-500 cause cancer?

Like BPC-157, TB-500 has theoretical angiogenic properties. No cancer-promoting effects have been demonstrated in animal studies, but caution is warranted in individuals with cancer history.

How does TB-500 compare to BPC-157 in terms of side effects?

Both peptides have similar mild side effect profiles. TB-500 is more commonly associated with brief head rush sensations immediately post-injection. BPC-157 is more commonly associated with nausea.

Does TB-500 affect hormones?

TB-500 does not appear to significantly affect sex hormone levels. It primarily acts on actin dynamics and wound healing pathways.

Can TB-500 be combined with BPC-157?

Many research protocols combine TB-500 and BPC-157. The combination is generally considered well-tolerated in animal models, but human data is limited.

Source Research-Grade TB-500

Purgo Labs provides HPLC-verified, third-party tested TB-500 for legitimate research purposes. Every batch includes a certificate of analysis.

Shop TB-500 at Purgo Labs

Related Research Guides

Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.